Aurora Europe

Aurora Europe

Headquartered in Berlin, Germany, Aurora Europe (www.auroramedicine.com) is one of the largest authorised importers and distributors of medical cannabis in the European Union. Aurora Europe is a subsidiary of the publicly listed cannabis producer, Aurora Cannabis Inc., which is headquartered in Edmonton, Alberta, Canada, with and sales and operations across five continents and 25 countries, 19 of which are in Europe, including Aurora Medicine España.
Aurora supplies high-quality medical cannabis products to patients throughout Europe and has been leading the German market since 2015. Aurora’s cannabis production and distribution facilities are certified under EU Good Manufacturing Practices (GMP), with a funded capacity of more than 625,000 kg of cannabis per year, making Aurora one of the world's largest and leading cannabis companies.

Synoptis

Synoptis

Synoptis Industrial is a European Good Manufacturing Practice (EU GMP) certified pharmaceutical importer, packing, and Qualified Person (QP) certification site. The company provides full end-to-end supply chain services, delivering pharmaceutical products from manufacturers to clients across Europe. Synoptis’ operations activity deals with the import and export of both regular and controlled pharmaceutical products, including cannabis products, and is covered by all relevant controlled drugs licenses where necessary. Synoptis Industrial is a part of the NEUCA Group, a leader in the pharmaceutical logistics and wholesale market in Poland.

Baker Tilly

Baker Tilly

At Baker Tilly, they believe in growth. Baker Tilly works today to make a difference for tomorrow. They successfully advised in obtaining the first-ever cannabis licence in Spain. And their work didn’t end there. Baker Tilly keeps working consistently with both their clients and regulator to develop and consolidate the Spanish legal cannabis market.

Epperly Elam

Epperly Elam

Epperly | Elam, LLP guides its cannabis operator and investor clients through venture-financing deals, corporate governance, regulatory compliance, and trans-border mergers and acquisitions. Most recently, the firm served as legal counsel on Terrascend's acquisition of the Apothecarium ($118M) and ABI (~$12M), as well serving as corporate counsel for Ebbu in its acquisition by Canopy ($429M).

Khiron Life Sciences

Khiron Life Sciences

Khiron Life Sciences is a fully vertically integrated medical cannabis company based in Colombia. In addition to its medical business, Khiron has developed the Kuida brand of CBD skin care products sold in Latam, USA & Europe. Khiron is publicly traded on the NY, Toronto & Frankfurt Stock Exchanges.

MGC Pharma

MGC Pharma

MGC Pharmaceuticals Ltd (ASX: MXC, OTCQB: MGCLF) is a European based bio-pharma company supplying phytocannabinoid derived medicines to patients globally. The Company’s founders were key figures in the global medical cannabis industry and the core business strategy is to develop and supply high quality phytocannabinoid derived medicines for the growing demand in the medical markets in Europe, North America and Australasia.

Prohibiton Partners

Prohibiton Partners

The world’s leading provider of cannabis intelligence with a blue-chip, cross-industry client base Prohibition Partners was founded in 2017 with a mission to open up the international cannabis industry through reliable data and intelligence.

Within two years Prohibition Partners has become the world’s leading provider of market intelligence and strategic consultancy for this emerging frontier. It is the only company with such widespread global coverage. The consultancy team works with investors, operators and regulators to identify and materialise opportunities across multiple jurisdictions.